A diabetes drug now on the NHS can buy your child three more years before insulin, and here’s how it works

The NHS begins offering teplizumab, the first drug shown to delay type 1 diabetes and postpone insulin by nearly three years.
WahanaRiau.com

Teva to Advance Its Anti-IL-15 Antibody, Designed for Quarterly Dosing, Into Phase 2b Development in Vitiligo, Following Encouraging Phase 1b Results

Teva-discovered TEV-’408 targets IL-15, a key driver of vitiligo biology TEV-’408 showed improvement in skin pigmentation and ...